info@marketresearchfuture.com 📞 +1 628 258 0071(US)  📞 +44 2035 002 764(UK)
Cholesterol Management Devices Market Research Report - Forecast to 2027

Cholesterol Management Devices Market Share, Growth And Trends Analysis Types (Monitors, Wrist Monitors, Small Portable Instruments, Meters, Wireless Systems), Application (Hypercholesterolemia, Hypocholesterolemia, Cholesterol Testing), End Users (Home Healthcare, Hospitals, And Clinics) - Forecast Till 2027

ID: MRFR/MED/0539-HCR | February 2021 | Region: Global | 110 pages

Cholesterol Management Devices Market Speak to Analyst Request a Free Sample

Cholesterol Management Devices Market Scenario:


Cholesterol is a type of lipid molecule, which is biosynthesized by all animal cells as it is an essential structural component of the cells. Cholesterol management devices are used to determine a lipoprotein profile and to measure total cholesterol content, high-density lipoprotein (HOL), low-density lipoprotein (LDL), triglycerides, and other fatty substances found in the human body. The cholesterol management devices market is driven by increasing obese and overweight population base. According to the World Health Organization (2014), worldwide, more than 1.9 billion adults over 18 years were overweight of which over 600 million were obese. Less physical activity due to the desk-bound nature of many forms of work, changing modes of transportation, government support for the research and development, and increasing urbanization have fueled the growth of the cholesterol management devices market. However, lack of awareness among the people may slow the growth of the cholesterol management devices market.


The Cholesterol Management Devices Market Is Expected To Grow At A CAGR Of 8.5% During The Forecast Period (2017-2023).


Segmentation


The cholesterol management devices market is segmented on the basis of types, application and end users. On the basis of types, the cholesterol management devices market is classified into monitors, wrist monitors, small portable instruments, meters, wireless systems, and others. On the basis of applications, the cholesterol management devices market is categorized into hypercholesterolemia, hypocholesterolemia, cholesterol testing, and others. On the basis of end users, the cholesterol management devices market is segmented into home based healthcare, hospitals, clinics, and others.


Intended Audience



  • Cholesterol Management Devices Manufacturer

  • Cholesterol Management Devices Supplier

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Regional Analysis


America continues to dominate the cholesterol management devices market owing to the presence of a huge number of people suffering from obesity and overweight. According to the Centers for Disease Control and Prevention (2014), 73.5 million adults in the US had diagnosed with high cholesterol level. Additionally, increasing awareness among the people regarding different monitoring procedures and well-developed technology have also contributed to the growth of the cholesterol management devices market. Europe is the second largest cholesterol management devices market, which is followed by Asia Pacific. Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population and continuously developing economies. On the other hand, the Middle East & Africa has the least share in the cholesterol management devices market.


Market Assessment


 Cholesterol Management Devices Market


Source- World Health Organization (WHO), white paper, company presentation, American Heart Association, National Institutes of Health, Centres for Disease Control and Prevention, annual reports


Key Players for Cholesterol Management Devices Market


Some of the key player in the cholesterol management devices market are Boston Scientific Corporation (US), Medtronic (US), St. Jude Medical, LLC. (Canada), Koninklijke Philips N.V. (US), Roche Diagnostics (US), Abbott (US), Alere (US), Sorin Group (Italy), BIOTRONIK SE & Co. KG (Germany), Bio-AMD (UK) and others.


The report for the cholesterol management devices market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   8.5% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Application and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Scientific Corporation (US), Medtronic (US), St. Jude Medical, LLC. (Canada), Koninklijke Philips N.V. (US), Roche Diagnostics (US), Abbott (US), Alere (US), Sorin Group (Italy), BIOTRONIK SE & Co. KG (Germany), Bio-AMD (UK) and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing obese and overweight population base
  • Changing modes of transportation
  • Government support for the research and development
  • Increasing urbanization


  • Speak to Analyst Ask for Customization